nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—ABCC10—Cyclosporine—focal segmental glomerulosclerosis	0.309	0.361	CbGbCtD
Daunorubicin—ABCB11—Cyclosporine—focal segmental glomerulosclerosis	0.168	0.196	CbGbCtD
Daunorubicin—ABCC1—Cyclosporine—focal segmental glomerulosclerosis	0.119	0.14	CbGbCtD
Daunorubicin—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.0882	0.103	CbGbCtD
Daunorubicin—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.0797	0.0934	CbGbCtD
Daunorubicin—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0442	0.0517	CbGbCtD
Daunorubicin—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0288	0.0337	CbGbCtD
Daunorubicin—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0172	0.0202	CbGbCtD
Daunorubicin—SLC22A2—nephron—focal segmental glomerulosclerosis	0.0121	0.182	CbGeAlD
Daunorubicin—TOP2B—nephron tubule—focal segmental glomerulosclerosis	0.0033	0.0495	CbGeAlD
Daunorubicin—ABCC6—kidney—focal segmental glomerulosclerosis	0.00319	0.0479	CbGeAlD
Daunorubicin—YWHAG—kidney—focal segmental glomerulosclerosis	0.00301	0.0451	CbGeAlD
Daunorubicin—XDH—kidney—focal segmental glomerulosclerosis	0.00293	0.044	CbGeAlD
Daunorubicin—YWHAG—cortex of kidney—focal segmental glomerulosclerosis	0.00293	0.0439	CbGeAlD
Daunorubicin—Doxorubicin—NOS2—focal segmental glomerulosclerosis	0.00291	1	CrCbGaD
Daunorubicin—TOP2B—kidney—focal segmental glomerulosclerosis	0.0029	0.0435	CbGeAlD
Daunorubicin—TOP2B—cortex of kidney—focal segmental glomerulosclerosis	0.00282	0.0424	CbGeAlD
Daunorubicin—SLC22A2—nephron tubule—focal segmental glomerulosclerosis	0.00262	0.0393	CbGeAlD
Daunorubicin—POR—nephron tubule—focal segmental glomerulosclerosis	0.0026	0.039	CbGeAlD
Daunorubicin—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.0319	CcSEcCtD
Daunorubicin—SLC22A2—kidney—focal segmental glomerulosclerosis	0.0023	0.0345	CbGeAlD
Daunorubicin—SLC22A2—cortex of kidney—focal segmental glomerulosclerosis	0.00224	0.0336	CbGeAlD
Daunorubicin—POR—cortex of kidney—focal segmental glomerulosclerosis	0.00223	0.0334	CbGeAlD
Daunorubicin—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.0288	CcSEcCtD
Daunorubicin—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00214	0.0279	CcSEcCtD
Daunorubicin—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.0254	CcSEcCtD
Daunorubicin—ABCC10—kidney—focal segmental glomerulosclerosis	0.00181	0.0272	CbGeAlD
Daunorubicin—ABCC10—cortex of kidney—focal segmental glomerulosclerosis	0.00177	0.0265	CbGeAlD
Daunorubicin—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.0222	CcSEcCtD
Daunorubicin—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.00166	0.0249	CbGeAlD
Daunorubicin—CYP1B1—nephron tubule—focal segmental glomerulosclerosis	0.00162	0.0244	CbGeAlD
Daunorubicin—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.0201	CcSEcCtD
Daunorubicin—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.0199	CcSEcCtD
Daunorubicin—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.0195	CcSEcCtD
Daunorubicin—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.0195	CcSEcCtD
Daunorubicin—ABCC2—kidney—focal segmental glomerulosclerosis	0.00146	0.0219	CbGeAlD
Daunorubicin—CYP1B1—kidney—focal segmental glomerulosclerosis	0.00143	0.0214	CbGeAlD
Daunorubicin—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.00142	0.0213	CbGeAlD
Daunorubicin—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.0184	CcSEcCtD
Daunorubicin—CYP1B1—cortex of kidney—focal segmental glomerulosclerosis	0.00139	0.0208	CbGeAlD
Daunorubicin—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.0181	CcSEcCtD
Daunorubicin—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.0176	CcSEcCtD
Daunorubicin—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.017	CcSEcCtD
Daunorubicin—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.0166	CcSEcCtD
Daunorubicin—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.0164	CcSEcCtD
Daunorubicin—ABCC1—cortex of kidney—focal segmental glomerulosclerosis	0.00125	0.0188	CbGeAlD
Daunorubicin—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.0158	CcSEcCtD
Daunorubicin—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.00121	0.0181	CbGeAlD
Daunorubicin—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.0157	CcSEcCtD
Daunorubicin—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.0154	CcSEcCtD
Daunorubicin—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.015	CcSEcCtD
Daunorubicin—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.015	CcSEcCtD
Daunorubicin—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.0147	CcSEcCtD
Daunorubicin—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00112	0.0168	CbGeAlD
Daunorubicin—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.0146	CcSEcCtD
Daunorubicin—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.0141	CcSEcCtD
Daunorubicin—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.014	CcSEcCtD
Daunorubicin—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0139	CcSEcCtD
Daunorubicin—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0138	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0136	CcSEcCtD
Daunorubicin—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0135	CcSEcCtD
Daunorubicin—CYP1A1—kidney—focal segmental glomerulosclerosis	0.00101	0.0151	CbGeAlD
Daunorubicin—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.000991	0.0129	CcSEcCtD
Daunorubicin—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000986	0.0148	CbGeAlD
Daunorubicin—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000961	0.0144	CbGeAlD
Daunorubicin—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.000954	0.0125	CcSEcCtD
Daunorubicin—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.000923	0.0121	CcSEcCtD
Daunorubicin—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000891	0.0116	CcSEcCtD
Daunorubicin—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00087	0.0114	CcSEcCtD
Daunorubicin—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000848	0.0111	CcSEcCtD
Daunorubicin—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000814	0.0106	CcSEcCtD
Daunorubicin—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000774	0.0101	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000765	0.00999	CcSEcCtD
Daunorubicin—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000763	0.00996	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000761	0.00993	CcSEcCtD
Daunorubicin—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000761	0.00993	CcSEcCtD
Daunorubicin—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000756	0.00988	CcSEcCtD
Daunorubicin—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000754	0.00985	CcSEcCtD
Daunorubicin—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00074	0.0111	CbGeAlD
Daunorubicin—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000728	0.00951	CcSEcCtD
Daunorubicin—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000698	0.00912	CcSEcCtD
Daunorubicin—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000671	0.00877	CcSEcCtD
Daunorubicin—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00065	0.00848	CcSEcCtD
Daunorubicin—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000647	0.00844	CcSEcCtD
Daunorubicin—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000625	0.00816	CcSEcCtD
Daunorubicin—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000622	0.00813	CcSEcCtD
Daunorubicin—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000616	0.00804	CcSEcCtD
Daunorubicin—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000596	0.00894	CbGeAlD
Daunorubicin—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000594	0.00776	CcSEcCtD
Daunorubicin—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000568	0.00742	CcSEcCtD
Daunorubicin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000563	0.00735	CcSEcCtD
Daunorubicin—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000561	0.00732	CcSEcCtD
Daunorubicin—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000557	0.00728	CcSEcCtD
Daunorubicin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000547	0.00714	CcSEcCtD
Daunorubicin—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000543	0.00709	CcSEcCtD
Daunorubicin—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000529	0.00691	CcSEcCtD
Daunorubicin—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000525	0.00686	CcSEcCtD
Daunorubicin—ABCB1—kidney—focal segmental glomerulosclerosis	0.000524	0.00786	CbGeAlD
Daunorubicin—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000524	0.00684	CcSEcCtD
Daunorubicin—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000516	0.00674	CcSEcCtD
Daunorubicin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000516	0.00674	CcSEcCtD
Daunorubicin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000516	0.00674	CcSEcCtD
Daunorubicin—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000515	0.00672	CcSEcCtD
Daunorubicin—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.00051	0.00766	CbGeAlD
Daunorubicin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.00666	CcSEcCtD
Daunorubicin—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000505	0.00659	CcSEcCtD
Daunorubicin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000499	0.00652	CcSEcCtD
Daunorubicin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000495	0.00646	CcSEcCtD
Daunorubicin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000495	0.00646	CcSEcCtD
Daunorubicin—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000492	0.00642	CcSEcCtD
Daunorubicin—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000485	0.00633	CcSEcCtD
Daunorubicin—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000479	0.00625	CcSEcCtD
Daunorubicin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000472	0.00616	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000451	0.00589	CcSEcCtD
Daunorubicin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000448	0.00585	CcSEcCtD
Daunorubicin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000441	0.00576	CcSEcCtD
Daunorubicin—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00044	0.00575	CcSEcCtD
Daunorubicin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00043	0.00562	CcSEcCtD
Daunorubicin—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000427	0.00557	CcSEcCtD
Daunorubicin—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000423	0.00553	CcSEcCtD
Daunorubicin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000423	0.00553	CcSEcCtD
Daunorubicin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000408	0.00533	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000405	0.00529	CcSEcCtD
Daunorubicin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000393	0.00513	CcSEcCtD
Daunorubicin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000391	0.00511	CcSEcCtD
Daunorubicin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000391	0.00511	CcSEcCtD
Daunorubicin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000365	0.00476	CcSEcCtD
Daunorubicin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000355	0.00464	CcSEcCtD
Daunorubicin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00035	0.00457	CcSEcCtD
Daunorubicin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000339	0.00442	CcSEcCtD
Daunorubicin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000327	0.00427	CcSEcCtD
Daunorubicin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000315	0.00411	CcSEcCtD
Daunorubicin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000312	0.00408	CcSEcCtD
Daunorubicin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000312	0.00407	CcSEcCtD
Daunorubicin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00031	0.00405	CcSEcCtD
Daunorubicin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000294	0.00384	CcSEcCtD
